Insight

Aug 2, 2025, 09:30

FASCO 2025: 44 Voices, One Mission

The title of Fellow of the American Society of Clinical Oncology (FASCO) is one of the highest honors conferred by the American Society of Clinical Oncology (ASCO). Introduced in 2007, this distinction is awarded annually to a select group of ASCO members who have demonstrated outstanding volunteer service, leadership, and commitment to ASCO’s mission.

Unlike awards based solely on academic or clinical achievements, FASCO is reserved for individuals who have made sustained, meaningful contributions to the oncology community through active involvement in ASCO programs, committees, publications, policy, and mentorship initiatives.

FASCO as a Symbol of Influence and Trust

Unlike awards focused purely on academic or clinical distinction, FASCO emphasizes organizational and community-oriented leadership. Recipients serve as trusted ambassadors for ASCO’s values shaping programs, influencing policy, and supporting the growth of the oncology workforce globally.

The 44 individuals honored in 2025 embody the critical link between clinical excellence and professional service. Their collective work reinforces ASCO’s global influence through mentorship, guideline development, educational leadership, and patient-centered advocacy.

FASCO 2025 Recipients

Images	Name
	Janet Abrahm, MD, FAAHPM, FACP, FASCO A Professor of Medicine at Harvard Medical School and Institute Physician at Dana‑Farber/Brigham & Women’s, Dr. Abrahm pioneered outpatient and inpatient palliative care services and launched a fellowship program in 2001. She has authored multiple leading books and over 150 papers on supportive oncology and was awarded ASCO’s Walther Cancer Foundation Supportive Oncology Award in 2024. Her leadership in patient-centered symptom management has shaped national palliative care education programs.
	Himisha Beltran, MD, FASCO Specializing in advanced prostate cancer, Dr. Beltran focuses on molecular mechanisms of resistance and neuroendocrine transformation. Her translational research has shaped emerging precision medicine strategies and gained recognition at national conferences.
	Janet Abrahm, MD, FAAHPM, FACP, FASCO Dr. Aragon‑Ching serves as Clinical Program Director for Genitourinary Oncology and holds a joint academic faculty position. She has led key clinical trials in prostate and bladder cancers and is known for excellence in mentoring and innovation in pharmacogenomic approaches.
	Nishin Bhadkamkar, MD, FASCO A seasoned gastrointestinal oncologist, Dr. Bhadkamkar has led multiple trials in colorectal cancer and contributed to national guidelines. He is a distinguished educator and long-time author in the field of translational oncology.
	Kathleen E. Bickel, MD, FACP, MPhil, FASCO Dr. Bickel practices thoracic oncology and is board-certified in internal medicine and palliative care. She co-developed national guidance on integrating supportive care into oncology and is known for her leadership in quality and education.
	Maria T. Bourlon, MD, MSc, FASCO As a medical oncologist in Mexico, Dr. Bourlon established her country’s first urologic oncology clinic and advances clinical research in cervical, bladder, and kidney cancers. She mentors early-career oncologists throughout Latin America and champions equitable access to care.
	Sam Brondfield, MD, MA, FASCO A lung and head-and-neck cancer specialist and educator, Dr. Brondfield is known for integrating teaching innovations into clinical care. He oversees hospital-based oncology consult services and develops novel educational programs for trainees.
	Mehmet Copur, MD, FACP, FASCO Dr. Copur is a longtime medical oncologist with expertise in endocrine and pediatric cancers. Known for international collaborations, he has led cross-disciplinary trials and promoted comprehensive care through decades of mentoring and leadership.
	Robert M. Daly, MD, MBA, FASCO This physician leader combines clinical thoracic oncology with health systems innovation, leveraging his MD and MBA background. His work centers on improving treatment delivery and patient access through digital and integrated care models.
	Rebecca Dent, MD, FASCO Dr. Dent is a breast and gynecologic oncology specialist whose research and clinical practice enhance outcomes in early-stage disease. As an educator and advocate, she promotes awareness and quality care in women’s cancers.
	Aakash Desai, MD, MPH, FASCO A clinician–scientist with expertise in gastrointestinal oncology and global health, Dr. Desai leads trials across continents and invests deeply in education and mentorship for physicians in resource-limited settings.
	Shirish M. Gadgeel, MD, FASCO Dr. Gadgeel is a thoracic oncologist with emphasis on immunotherapies for lung cancer. He drives clinical trials, leads multidisciplinary tumor boards, and is recognized for bridging research and patient care.
	Sanjay Goel, MD, MS, FASCO Specializing in gastrointestinal oncology, Dr. Goel focuses on colorectal and pancreatic cancer research, particularly in molecularly stratified trials. He is a respected teacher and institutional leader in oncology education.
	Michael S. Gordon, MD, FASCO A breast cancer expert, Dr. Gordon has actively contributed to early-phase clinical trials and cancer drug development. His leadership in trial design and translational research is widely recognized.
	Sharad Goyal, MD, MS, FASTRO, FASCO A specialist in radiation oncology and gastrointestinal malignancies, Dr. Goyal is known for combining radiotherapy innovation with systemic treatment. His mentorship spans radiation and medical oncology trainees alike.
	Stacy W. Gray, MD, FASCO Dr. Gray’s work spans service delivery, health policy, and patient engagement. She leads research on decision-making in oncology and has shaped national guidelines for care in diverse populations.
	Petros Grivas, MD, PhD, FASCO A genitourinary medical oncologist, Dr. Grivas conducts pivotal research in bladder and prostate cancer trials. He balances laboratory and clinical leadership and is a prolific mentor in translational medicine.
	Arjun Gupta, MD, FASCO Dr. Gupta specializes in head-and-neck and gastrointestinal oncology, contributing to early clinical trials and diagnostics. He is recognized for combining educational activities with patient-centered clinical work.
	Shilpi Gupta, MD, FASCO Dr. Gupta directs research and care in pancreas and hepatobiliary cancers. She leads innovative trial designs and advocates for equitable clinical trial access and patient education.
	Jack Hensold, MD, FASCO A genitourinary oncologist, Dr. Hensold supports practice innovation in kidney and urologic cancers. He is known for mentorship in both clinical and academic oncology settings.
	Richard M. Ingram, MD, FASCO Dr. Ingram is a medical oncologist focused on GI cancers, translational research, and health services improvement. He has led multidisciplinary teams and contributed to national oncology research consortia.
	Claudine Isaacs, MD, FRCPC, FASCO Dr. Isaacs is a global oncology leader working across breast cancer control, policy, and education. She has contributed to international cancer guidelines and champions disparities research and equity.
	Steve Lee, MD, FACP, FASCO A physician-scientist in medical oncology, Dr. Lee’s focus is on translational discoveries in colorectal cancer. He combines clinical care with efforts to expand research infrastructure and education in GI oncology.
	Inga T. Lennes, MD, MPH, MBA, FASCO Dr. Lennes blends oncology, public health, and health policy, working to advance cancer care equity. She leads quality improvement and advocacy programs within academic cancer centers.
	Sagar Lonial, MD, FACP, FASCO A global leader in multiple myeloma, Dr. Lonial has shaped treatment paradigms through academic and cooperative group trials. He is highly regarded as a mentor to trainees and peers in hematologic oncology.
	Alison W. Loren, MD, MSCE, MS, FACP, FASCO Dr. Loren is a gynecologic oncology specialist with expertise in clinical trial design, outcomes research, and cancer prevention. She serves in leadership roles and mentors across clinical and research domains.
	Issam Makhoul, MD, FASCO An expert in genitourinary malignancies, Dr. Makhoul leads molecularly informed clinical trials and translational research in advanced urothelial and prostate cancers.
	Heather L. McArthur, MD, MPH, FASCO Dr. McArthur is a breast oncologist focusing on novel endocrine therapies and survivorship. She leads collaborative research efforts on adjuvant treatment optimization and patient-reported outcomes.
	Paul L. Nguyen, MD, MBA, FASCO Dr. Nguyen combines cardiology and oncology training in cardio-oncology work and breast cancer treatment trials. He is recognized for leadership in survivorship care and multidisciplinary care models.
	Ryan D. Nipp, MD, FASCO A palliative oncology specialist, Dr. Nipp advances research on quality of life and supportive care interventions. He is a leader in integrating serious illness communication training into oncology fellowship programs.
	Amy C. Peterson, MD, FASCO Dr. Peterson is a thoracic oncologist known for her leadership in patient advocacy and clinical trials design. She mentors trainees in advanced therapies and personalized oncology.
	Tycel J. Phillips, MD, FASCO A leukemia expert, Dr. Phillips has led pivotal clinical trials and translational investigations in hematologic malignancies. He is recognized for developing novel targeted treatment protocols.
	Deepa Rangachari, MD, FASCO Dr. Rangachari specializes in thoracic oncology and molecular therapeutics. She leads research on targeted and immune-based treatments and is a sought-after speaker at major oncology meetings.
	Mina S. Sedrak, MD, MS, FASCO An oncogeriatric specialist, Dr. Sedrak develops care strategies for older adults with cancer. She leads programs in survivorship and functional assessment in geriatric oncology.
	Lesley K. Seymour, MD, PhD, FASCO A public health-oriented oncologist, Dr. Seymour works on tobacco control, survivorship, and health systems. Her leadership spans research, teaching, and global cancer control initiatives.
	Surendranath S. Shastri, MD, DPH, FASCO Dr. Shastri is a leader in global oncology, public health, and cervical cancer prevention. He has conducted large-scale screening programs and shaped regional cancer policy frameworks.
	Joseph A. Sparano, MD, FACP, FASCO A breast cancer medical oncologist, Dr. Sparano directs clinical research to improve outcomes in metastatic and early-stage disease. He has led trials that shaped modern treatment guidelines.
	Tom Stinchcombe, MD, FASCO Dr. Stinchcombe specializes in lung cancer clinical trials and multidisciplinary care innovations. He has held leadership roles in cooperative oncology organizations and mentorship programs.
	Erica M. Stringer‑Reasor, MD, FASCO Dr. Stringer‑Reasor is a lung cancer expert with a focus on precision medicine. She integrates genomic profiling into clinical decision-making and advocates for trial access in underrepresented communities.
	Jason Westin, MD, MS, FACP, FASCO Dr. Westin leads gastrointestinal cancer research, with a focus on early-phase trials and biomarker-driven therapies. He is known for combining laboratory science with patient care in translational oncology.
	Robert A. Wolff, MD, FASCO A pancreatic and GI cancer specialist, Dr. Wolff has led multicenter clinical trials and contributed extensively to treatment guidelines. His contributions span patient care, education, and international research collaborations.
	Yun Yen, MD, PhD, FACP, FASCO Dr. Yen is an academic oncologist focusing on solid tumors and survivorship. His work integrates clinical care with translational research and leadership in multidisciplinary oncology teams.

Written by Nare Hovhannisyan, MD

Aakash Desai Alison W. Loren Amy C. Peterson Arjun Gupta cancer Claudine Isaacs Deepa Rangachari Erica M. Stringer‑Reasor FASCO Heather L. McArthur Himisha Beltran Inga T. Lennes Issam Makhoul Jack Hensold Janet Abrahm Jason Westin Joseph A. Sparano Kathleen E. Bickel Lesley K. Seymour Maria T Bourlon Mehmet Copur Michael S. Gordon Mina S. Sedrak Nishin Bhadkamkar OncoDaily Oncology Paul L. Nguyen Petros Grivas Rebecca Dent Richard M. Ingram Robert A. Wolff Robert M. Daly Ryan D. Nipp Sagar Lonial Sam Brondfield Sanjay Goel Sharad Goyal Shilpi Gupta Shirish M. Gadgeel Stacy W. Gray Steve Lee Surendranath S. Shastri Tom Stinchcombe Tycel J. Phillips Yun Yen

FDA Priority Review Granted for TAR-200 After 82% Complete Response in BCG-Unresponsive Bladder Cancer

Top 10 Immunotherapy Fellowships and Grants to Watch in 2025

July Is Sarcoma Awareness Month: What You Need to Know

Pat Soon-Shiong: SARS-CoV-2 Infection Can Awaken Sleeping Cancer Cells

Cary Adams' Keynote Message at Parliament House in Canberra - UICC